IS THERE AN ADVANTAGE OF MONITORING VIA EXOSOME-BASED DETECTION OF EGFR MUTATIONS DURING TREATMENT IN NON-SMALL CELL LUNG CANCER PATIENTS?

Autor: KARAGUR, Ege Riza1, DEMIRAY, Aydin1, KARAGENC, Nedim1, ELVER, Esra2, TOKGUN, Onur1, YAREN, Arzu3, DOGU, Gamze G.3, AKCA, Hakan1 hakca@pau.edu.tr
Zdroj: Genetika (0534-0012). 2023, Vol. 55 Issue 1, p83-93. 11p.
Databáze: Academic Search Ultimate